Why This Number in Moderna's Earnings Report Isn't as Bad as It Looks
6/11 11:00
Vaccine giant Moderna (NASDAQ: MRNA) had been spoiling us. We'd gotten used to quarter after quarter of excellent news. And then, in the third-quarter earnings report this week, Moderna cut its 2021 vaccine revenue forecast. Moderna said it now predicts $15 billion to $18 billion...